The continuing hormonal contamination of insulin

T. E. Adrian, S. R. Bloom

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)


The content of four pancreatic regulatory peptides was measured in 75 commercial insulins. Most products had very small amounts of hormonal contaminants but the insulins of three manufacturers contained substantial amounts of glucagon (up to 250 fmol/U) and the products of two had higher concentrations of pancreatic polypeptide (up to 170 fmol/U). Chromatography revealed considerable amounts of high molecular weight glucagon and pancreatic polypeptide in several insulins, which suggests that current purification procedures may selectively purify hormone precursors. The concentrations of these contaminating hormones is too low to exhibit any pharmacological effect. However, they may still be sufficient to induce an autoimmune response to the systems in question. The measurement of these hormonal contaminants is a useful indicator of the purity of commericial insulin preparations.

Original languageEnglish
Pages (from-to)34-36
Number of pages3
JournalPractical Diabetes International
Issue number6
Publication statusPublished - 1985
Externally publishedYes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism


Dive into the research topics of 'The continuing hormonal contamination of insulin'. Together they form a unique fingerprint.

Cite this